Skip to main content
Clinical Trials/JPRN-C000000315
JPRN-C000000315
Completed
未知

EFFECTS of BLOOD PRESSURE LOWERING and ANTIHYPERTENSIVE DRUG CLASS on SURVIVAL and CARDIOVASCULAR EVENTS of HEMODIALYSIS PATIENTS: - Hemodialysis Heart Angiotensin-Inhibition Rescue Trial (HHEART) Randomized Clinical Trial

Div. Nephrology, GenGen-Do Kimitsu Hospital0 sites400 target enrollmentFebruary 1, 2006

Overview

Phase
未知
Intervention
Not specified
Conditions
Hypertensive patients undergoing trice-weekly hemodialysis
Sponsor
Div. Nephrology, GenGen-Do Kimitsu Hospital
Enrollment
400
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2006
End Date
May 1, 2003
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Div. Nephrology, GenGen-Do Kimitsu Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • patients with preserved residual renal function (urine volume of more than 500 mL per day), pre\-dialysis BP of less than 140/60 mm Hg, unstable homodynamic during hemodialysis therapy, a history of drug\-allergy, accelerated or malignant hypertension within six months, secondary hypertension, severe systemic diseases, including cardio\-,cerebro\- and peripheral vascular, pulmonary, and gastrointestinal and hepatic diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials